Webinars
Scale Up & Tech Transfer of Fluid Bed Coating Processes
Summary: This webinar provides an introduction and comparison of top-spray and bottom-spray fluid bed coating technologies and how to select the most appropriate technique to meet the target product profile.
View Now
Executive Summary
Is My Molecule Suitable for an Orally Disintegrating Tablet?
Summary: While new drug products may benefit from ODT formulation beginning with product launch, ODT formulation can also play a role in life cycle management of approved products.
View Now
Webinars
Effective Scale-Up and Technology Transfer Strategies for Spray Dried Pharma Products
Summary: In this webinar, learn from real world case studies about best practices and strategies to mitigate risks and ensure a successful tech transfer from development through to commercial scale spray drying of pharmaceutical products.
View Now
eBook
Pharmaceutical Outsourcing for Oral Development and Manufacturing
Summary: This eBook includes an overview of outsourcing trends in the oral solid dose market. Featured articles describe the robust market resulting from the demand for specialized dosage forms such as controlled release, pediatric and geriatric delivery vehicles.
View Now
Offering Fact Sheet
OptiForm® Solution Suite Bio Capabilities Sheet
OptiForm® Solution Suite Bio is designed to rapidly screen biomolecules’ potential for a non-invasive delivery route.
View Now
Article
Article: Industry Trend: Examining the Emergence of Unit- & Bi-Dose Nasal Sprays
Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or...
View Now
eBook
Orally Inhaled & Nasal Drug Delivery – An Evolving Pipeline Creating New Opportunities
Catalent’s Carla Vozone discusses the significant inhalation trends including those in larger molecules and novel indications.
View Now
Article
Selecting the Most Suitable Dosage Form Technology for the Oral Delivery of Lipid-Based Formulations
Summary: Lipid-based drug delivery systems have found widespread acceptance for development of drug products containing developability challenged APIs.
View Now
Article
Exclusive Orphan Drugs Industry Survey Results Desire to Treat Rare Diseases Tempered by a Lack of Internal Expertise and Capability
Summary: Orphan drugs face obstacles that span from discovery to launch, largely because of small patient populations and limited markets for rare disease therapies.
View Now
Offering Fact Sheet
OneXpress Solution Capabilities Sheet
Summary: OneXpress® is a single integrated solution that provides the fastest pathway from clinical to commercial manufacturing.
View Now